Sign Out
TS-ONE is indicated in adults: For the treatment of advanced gastric cancer (unresectable advanced gastric cancer) when given in combination with cisplatin or when given as monotherapy (for patients who are intolerant to cisplatin).
For the post-operative adjuvant treatment of locally advanced gastric cancer when given as monotherapy.
For the treatment of non-small cell lung cancer (locally advanced or unresectable or metastasis) when given in combination with carboplatin.
For the treatment of non-small cell lung cancer in patients who have received a platinum-based treatment when given as monotherapy.
For the treatment of colorectal cancer (locally advanced or unresectable or metastasis) when given in combination with oxaliplatin as first-line treatment, or in combination with irinotecan as second-line treatment.
For the treatment of pancreatic cancer (locally advanced or unresectable or metastasis) when given as monotherapy.
For the post-operative adjuvant chemotherapy for pancreatic cancer when given as monotherapy.
For the treatment of metastatic HER-2 negative breast cancer when given as monotherapy.
Continue with Google